Aliskiren in Combination With Amlodipine in Hypertensive Patients Not Responding to Angiotensin Receptor Blocker (ARB) Plus Amlodipine

NCT01113047 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

347

Enrollment

INDUSTRY

Sponsor class

Conditions

Essential Hypertension

Interventions

DRUG: Aliskiren/Amlodipine and Aliskiren/Amlodipine/HCTZ

Sponsor

Novartis